Jeff bezos backed wildtype just got fda approval to sell lab grown salmon.

In early June 2025, Wildtype, a San Francisco-based startup specializing in cultivated seafood, became the first company to receive FDA approval to sell lab-grown salmon. This approval marks a significant milestone as it is the first-ever cultivated fish product authorized for human consumption by the FDA. Jeff Bezos, through his investment arm Bezos Expeditions, is one of the notable backers of Wildtype, alongside other investors such as Leonardo DiCaprio and Cargill.

The FDA's approval followed a safety consultation process, making Wildtype only the fourth company to gain regulatory clearance for cell-cultivated animal products. The cultivated salmon is sushi-grade and produced through cellular agriculture techniques that replicate oceanic conditions without harvesting wild fish. Following the approval, Wildtype has begun launching its product in select restaurants across the U.S., signaling the start of commercial availability.

While some sources raise concerns about the FDA's reliance on manufacturer safety claims without independent data, the official regulatory stance confirms that Wildtype's lab-grown salmon meets safety standards for sale and consumption. This development is part of a broader trend toward sustainable and innovative food technologies aiming to reduce environmental impact and overfishing.